TEOSYAL® PURESENSE GLOBAL ACTION

Product Overview: TEOSYAL® PURESENSE GLOBAL ACTION

TEOSYAL® PURESENSE GLOBAL ACTION is an injectable, non-pyrogenic, transparent viscoelastic gel composed of cross-linked hyaluronic acid (HA) of non-animal origin, integrated with 0.3% lidocaine hydrochloride for enhanced patient comfort. Manufactured by Teoxane Laboratories (Geneva, Switzerland), this formulation is designed as a versatile filler for the mid-dermis.

It is specifically indicated for the correction of mild to moderate facial wrinkles and lines, aiming to address early signs of aging and improve overall skin texture in the treated areas.

Note: This medical device is intended for use only by licensed medical professionals trained in dermal filler injection techniques.

Mechanism of Action and Properties

TEOSYAL® PURESENSE GLOBAL ACTION works by physically augmenting the dermal tissue upon injection into the mid-dermis. The cross-linked hyaluronic acid gel provides volume to fill and smooth mild to moderate wrinkles and lines. Its rheological properties are balanced to allow for effective filling and integration within the dermal layer, providing a natural-looking correction. The hyaluronic acid component also contributes to local skin hydration by attracting water molecules.

The inclusion of 0.3% lidocaine hydrochloride acts as a local anesthetic to minimize pain during and immediately after the injection procedure.

The clinical duration of effect typically lasts for several months, potentially up to approximately 12 months, although this can vary based on individual patient factors (metabolism, skin type, lifestyle), the area treated, volume injected, and practitioner technique.

Indications and Usage

TEOSYAL® PURESENSE GLOBAL ACTION is indicated for the correction of mild to moderate facial wrinkles and lines, including:

• Glabellar lines (between the eyebrows)
• Mild to moderate nasolabial folds
• Perioral wrinkles (around the mouth)
• Mild marionette lines
• Other superficial to moderate facial creases

Administration involves injection into the mid-dermis using appropriate techniques and aseptic precautions by qualified practitioners.

Expected Outcomes

Professional application aims to achieve:

• Effective smoothing of mild to moderate facial wrinkles and lines
• A natural-looking rejuvenation of the treated areas
• Improved skin texture and hydration locally
• Enhanced overall facial appearance

Potential Adverse Events

Practitioners must inform patients about potential side effects associated with dermal filler injections. Possible adverse events include:

• Common Reactions (Typically Mild and Transient): Injection site reactions such as redness (erythema), swelling (edema), bruising, pain, tenderness, itching, or temporary palpable firmness/lumps. These usually resolve within a few days. Temporary loss of sensitivity near the injection site may occur.
• Less Common/Rare but Serious Reactions: Persistent swelling or induration, significant hematoma, infection, inflammatory reactions (which may be delayed), hypersensitivity/allergic reactions, formation of nodules or granulomas, skin discoloration, abscess formation, implant migration, vascular complications (including accidental intravascular injection leading to ischemia, necrosis, or embolism – rare but serious).

Thorough knowledge of facial anatomy, safe injection techniques, and management of potential complications is essential. Patients should report any severe, persistent, or concerning reactions immediately.

Storage Conditions

Store between 2°C and 25°C. Protect from freezing and direct sunlight. Verify package integrity before use.

Disclaimer: This information serves as a general overview. Medical professionals must consult the full instructions accompanying TEOSYAL® PURESENSE GLOBAL ACTION before administration for comprehensive details on indications, contraindications, warnings, precautions, injection techniques, and potential adverse events.